Menü
sharewise sharewise
Einloggen
Registrieren
Einloggen
Registrieren
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von BMO Capital Markets 

Intellia Therapeutics Inc diskutieren

Intellia Therapeutics Inc

WKN: A2AG6H / Symbol: NTLA / Name: Intellia / Aktie / Biotechnologie & medizinische Forschung / Small Cap /

13,23 €
12,44 %

22 6
22
6

Intellia Therapeutics (NTLA) was upgraded by William Blair from "market perform" to "outperform".
Ratings data for NTLA provided by MarketBeat

William Blair 
0
Melden Teilen
19:15 Buy 1,89 %
Noch kein Mitglied? Jetzt kostenlos registrieren!

Neueste Beiträge

Jefferies_Financial_ in Aerovironment diskutieren
AeroVironment (AVAV) had its "buy" rating reaffirmed by J...
23:00
BWS_Financial in Trimas Corp. diskutieren
TriMas (TRS) had its "buy" rating reaffirmed by BWS Finan...
22:15
Barrington_Research in Cra International Inc. diskutieren
Charles River Associates (CRAI) had its "outperform" rati...
22:15
UBS_Group_AG in Tutor Perini Corp. diskutieren
Tutor Perini (TPC) had its price target raised by UBS Gro...
22:15
UBS_Group_AG in Hannon Armstrong diskutieren
HA Sustainable Infrastructure Capital (HASI) had its pric...
22:15
DA_Davidson in Arcosa Inc diskutieren
Arcosa (ACA) had its price target raised by DA Davidson f...
21:30
Canaccord_Genuity_Gr in Rhythm Pharmaceuticals diskutieren
Rhythm Pharmaceuticals (RYTM) had its price target lowere...
20:30
Cantor_Fitzgerald in Sterling Con diskutieren
Sterling Infrastructure (STRL) had its price target raise...
20:30
Mehr anzeigen